Medios AG (FRA:ILM1)

Market Cap	323.41M
Revenue (ttm)	1.91B
Net Income (ttm)	14.94M
Shares Out	n/a
EPS (ttm)	0.59
PE Ratio	21.65
Forward PE	12.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	350
Average Volume	249
Open	12.62
Previous Close	12.62
Day's Range	12.62 - 12.62
52-Week Range	10.32 - 18.52
Beta	n/a
RSI	56.07
Earnings Date	Aug 13, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2016
• Employees: 952
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.